CN110448579A - A kind of quick anti-trioxypurine formula - Google Patents

A kind of quick anti-trioxypurine formula Download PDF

Info

Publication number
CN110448579A
CN110448579A CN201910853787.9A CN201910853787A CN110448579A CN 110448579 A CN110448579 A CN 110448579A CN 201910853787 A CN201910853787 A CN 201910853787A CN 110448579 A CN110448579 A CN 110448579A
Authority
CN
China
Prior art keywords
cordyceps militaris
trioxypurine
maltodextrin
maltitol
oligofructose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910853787.9A
Other languages
Chinese (zh)
Inventor
栗立杨
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Hanzangjin Biotechnology Co Ltd
Original Assignee
Beijing Hanzangjin Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Hanzangjin Biotechnology Co Ltd filed Critical Beijing Hanzangjin Biotechnology Co Ltd
Priority to CN201910853787.9A priority Critical patent/CN110448579A/en
Publication of CN110448579A publication Critical patent/CN110448579A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/062Ascomycota
    • A61K36/066Clavicipitaceae
    • A61K36/068Cordyceps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides a kind of quick anti-trioxypurine formula, and the raw material of the recipe ingredient include Cordyceps militaris extract, oligofructose, maltitol, maltodextrin;The raw-material weight component of the recipe ingredient is as follows: Cordyceps militaris extract 1-2g, oligofructose 1-3g, maltitol 0.8-2g, maltodextrin 0.5-3g.The present invention can play the role of quickly reducing uric acid level, repair damaging cells, promote metabolism, prevent gout.

Description

A kind of quick anti-trioxypurine formula
Technical field
The present invention relates to pharmaceutical technology field, in particular to a kind of quick anti-trioxypurine formula.
Background technique
As economic level improves the change with people life style and diet structure, the hair of gout and hyperuricemia Sick rate is worldwide presented ascendant trend, and China's Patients with Hyperuricemia number is up to 1.7 hundred million, and wherein patient with gout is more than 80000000 people, and just increased sharply with annual 9.7% growth rate.It is expected that the year two thousand twenty, gout number is up to 100,000,000.Height urine Acidaemia usually with hyperlipidemia, high blood pressure, do by the diseases such as diabetes B, obesity, atherosclerosis, coronary heart disease Method, and and blood vessel, heart, kidney is bad closely related, seriously threatens human health.
High lithemia symptom can cause gout, and sudden arthritis often occurs at night in patient with gout, and morbidity is anxious, There is serious pain, oedema, redness and inflammation in joint part, and big toe is burnt equally, felt bad extremely, people with high uric acid is opened Begin frightened complication, and many patient with gout cannot be alleviated and treat, eventually dead because of kidney failure.
There are mainly two types of the drug markets of existing treatment hyperuricemia, and one kind is alkalinity, neutralizes intracorporal acidity, and another One kind is diuretics, promotes the excretion of kidney, uric acid is excluded in vitro, therefore general to current high lithemia symptom effect, and It can not prevent the generation of gout.The effect of data and existing drug and health care product for the people with high uric acid of rising, I Strive to find a kind of food that can intervene people with high uric acid, effect through diet helps people with high uric acid to improve body, Prevent gout, and alleviates the pain sensation for having broken out gout patient.
Summary of the invention
The purpose of the present invention is to provide a kind of quick anti-trioxypurine formula, the present invention, which can play, quickly reduces uric acid level Effect repairs damaging cells, promotes metabolism, prevents gout.
The purpose of the present invention is be achieved by following technical proposals: a kind of quick anti-trioxypurine formula, the formula group The raw material divided include Cordyceps militaris extract, oligofructose, maltitol, maltodextrin;The raw material weight of the recipe ingredient It is as follows to measure component: Cordyceps militaris extract 1-2g, oligofructose 1-3g, maltitol 0.8-2g, maltodextrin 0.5-3g.
As a kind of perferred technical scheme: the raw-material weight component of the recipe ingredient is as follows: Cordyceps militaris extract 1-1.5g, oligofructose 1-2g, maltitol 1-1.5g, maltodextrin 0.5-2g.
As a kind of perferred technical scheme: the raw-material weight component of the recipe ingredient is as follows: Cordyceps militaris extract 1.25mg, oligofructose 1.5g, maltitol 1.25g, maltodextrin 1g.
A kind of quick anti-trioxypurine formula, the preparation method is that:
S1: carrying out low temperature drying for the Cordyceps militaris of harvesting, rear to crush --- to impregnate --- enzymatic hydrolysis --- homogeneous --- secondary water Mentioning -- spray drying obtains the Cordyceps militaris extract rich in cordycepin and selenium;
S2: mixing after oligofructose, maltitol, maltodextrin, Cordyceps militaris extract are sieved respectively, spare;
S3: the mixture in step 2 is sieved again, is then put into blender and is mixed;
S4: the mixture in step 2 is put into one-step-granulating method, carries out granulating process;
S5: mixture is cooling, and sterile workshop completes canned molding.
As a kind of perferred technical scheme: 80 mesh of grit number was mixed in the S2.
As a kind of perferred technical scheme: mixture crosses grit number 150-200 mesh in the S3.
As a kind of perferred technical scheme: by purple before oligofructose, maltitol, maltodextrin mixing in the S4 Outside line irradiation, irradiation time 2 hours.
Compared with prior art, the winning feature that the present invention has the prior art and can not reach is:
The present invention is safe, without side-effects, can quickly reduce uric acid level and reduce uric acid synthesis, from root reduction uric acid, clearly Except inflammatory reaction, increase discharge capacity, promote kidney and intestine beneficial bacteria colony growth promote excretion increase high osmosis, repair by Cell is damaged, eubolism is restored.
Specific embodiment
Below in conjunction with the embodiment of the present invention, technical scheme in the embodiment of the invention is clearly and completely described, Obviously, described embodiments are only a part of the embodiments of the present invention, instead of all the embodiments, based in the present invention Embodiment, every other embodiment obtained by those of ordinary skill in the art without making creative efforts, all Belong to the scope of protection of the invention.
A kind of quick anti-trioxypurine formula, which is characterized in that the raw material of the recipe ingredient include Cordyceps militaris extract, low Fructooligosaccharides, maltitol, maltodextrin;The raw-material weight component of the recipe ingredient is as follows: Cordyceps militaris extract 1-2g, low Fructooligosaccharides 1-3g, maltitol 0.8-2g, maltodextrin 0.5-3g.
Specific embodiment one
The raw-material weight component of the recipe ingredient is as follows: Cordyceps militaris extract 1-1.5g, oligofructose 1-2g, malt Sugar alcohol 1-1.5g, maltodextrin 0.5-2g.
It is described the preparation method is as follows:
S1: carrying out low temperature drying for the Cordyceps militaris of harvesting, rear to crush --- to impregnate --- enzymatic hydrolysis --- homogeneous --- secondary water Mentioning -- spray drying obtains the Cordyceps militaris extract rich in cordycepin and selenium;
S2: mixing after oligofructose, maltitol, maltodextrin, Cordyceps militaris extract are sieved respectively, spare;
S3: the mixture in step 2 is sieved again, is then put into blender and is mixed;
S4: the mixture in step 2 is put into one-step-granulating method, carries out granulating process;
S5: mixture is cooling, and sterile workshop completes canned molding.
Specific embodiment two
The raw-material weight component of the recipe ingredient is as follows: Cordyceps militaris extract 1.25g, oligofructose 1.5g, malt Sugar alcohol 1.25g, maltodextrin 1g.
It is described the preparation method is as follows:
S1: carrying out low temperature drying for the Cordyceps militaris of harvesting, rear to crush --- to impregnate --- enzymatic hydrolysis --- homogeneous --- secondary water Mentioning -- spray drying obtains the Cordyceps militaris extract rich in cordycepin and selenium;
S2: mixing after oligofructose, maltitol, maltodextrin, Cordyceps militaris extract are sieved respectively, spare;
S3: the mixture in step 2 is sieved again, is then put into blender and is mixed;
S4: the mixture in step 2 is put into one-step-granulating method, carries out granulating process;
S5: mixture is cooling, and sterile workshop completes canned molding.
80 mesh of grit number was mixed in the S2.
Mixture crosses grit number 150-200 mesh in the S3.
It is irradiated before oligofructose, maltitol, maltodextrin mixing by ultraviolet light in the S4, irradiation time 2 hours.
The sugar alcohol it is low in calories, low G I, metabolic process without insulin participate in and not by oral microorganism decompose utilize Etc. all having good value medical health care, therefore the patient that sugar alcohol needs to control diet heat to diabetes, obesity etc. has Benefit, while also playing the role of pre- anti-caries, improving function of intestinal canal.In addition, maltitol, lactitol, sorbierite, mannitol is quiet Arteries and veins infusion preparation is also clinically common dehydrated pharmaceutical, and other sugar alcohols that hesitate in maltitol relax bowel and defecation after tested, can Favorably uric acid to be excluded.
It can inhibit xanthine oxidase rich in beneficiating ingredients such as cordycepin, selenium, Cordyceps sinensis polysaccharides in Cordyceps militaris extract in the present invention Change enzymatic activity, inhibits uric acid synthesis.Creatinine, the uric acid level in hyperuricemia serum are reduced, is prevented and treated from the source of generation Hyperuricemia is broken out.
The uric acid is the excretion pathway by kidney.The main excretion pathway of Uric Acid is exactly the renal tubule filtering through kidney Metabolism.The vigor of kidney antioxidase can be enhanced in Cordyceps militaris, improves glomerular filtration, promotes the Regeneration and Repair of renal tubule. Delay renal hypofunction, inhibits the remaining glomerulosclerosis of nephridial tissue and the development of renal tubular-interstitial injury, improve renal tubule pair The metabolism of uric acid.Uric acid is also by large intestine excretion pathway simultaneously.Normal person daily about 1/3 uric acid in enteron aisle, warp Some intestinal beneficial bacterium degradation treatments are crossed, prebiotics (oligofructose) contained in formula can promote intestinal beneficial bacterium all living creatures It is long, accelerate the metabolism to uric acid.
The cordycepin is natural anti-inflammatory factors, and adjustable inflammatory reaction, and intervening rapidly reduces pain, in addition Cordycepin is nucleoside derivate again, can rapidly enter cell, repairs damaged cell, is metabolized back to human body and reforms often.
Efficient combination of the present invention can quickly reduce uric acid content according to the formula after appropriate compatibility as with Cordyceps militaris, The activity and molecular structure of cordycepin are not changed in extraction Cordyceps militaris process simultaneously, the pharmacological property of drug is with more steady upon mixing It is qualitative.
According to clinical statistics analysis shows that, investigation is sampled to the patient for taking this product, verifies clinical effectiveness, especially taken out 25 hyperuricemia patients are taken, wherein male patient 20, female patient 5, oldest 50 years old, minimus 25 years old, Without important organ diseases such as serious angiocarpy, kidney, lungs.
The inventive formulation of 1 month dosage is provided for 25 patients, it is early to take after the meal, first day, uric acid number was measured on an empty stomach Value, after take product 1 and as a child measure uric acid numerical value again, and record data, be measured as in the 7th day morning, surveying on an empty stomach for the third time Uric acid level is measured, measures on an empty stomach the 4th morning for being measured as the 28th day, records data, and compare.
Measuring instrument: three promise uric acid measurement instrument.
Correlation data result record is as follows:
Data comparison is shown, takes product for a period of time, and reducing occurs in uric acid numerical value, and the ratio that reduces the moon is 12%.
It is obvious to a person skilled in the art that invention is not limited to the details of the above exemplary embodiments, Er Qie In the case where without departing substantially from spirit or essential attributes of the invention, the present invention can be realized in other specific forms.Therefore, no matter From the point of view of which point, the present embodiments are to be considered as illustrative and not restrictive, and the scope of the present invention is by appended power Benefit requires rather than above description limits, it is intended that all by what is fallen within the meaning and scope of the equivalent elements of the claims Variation is included within the present invention.
In addition, it should be understood that although this specification is described in terms of embodiments, but not each embodiment is only wrapped Containing an independent technical solution, this description of the specification is merely for the sake of clarity, and those skilled in the art should It considers the specification as a whole, the technical solutions in the various embodiments may also be suitably combined, forms those skilled in the art The other embodiments being understood that.

Claims (7)

1. a kind of quick anti-trioxypurine formula, which is characterized in that the raw material of the recipe ingredient include Cordyceps militaris extract, oligomeric Fructose, maltitol, maltodextrin;The raw-material weight component of the recipe ingredient is as follows: Cordyceps militaris extract 1-2g, oligomeric Fructose 1-3g, maltitol 0.8-2g, maltodextrin 0.5-3g.
2. a kind of quick anti-trioxypurine formula according to claim 1, it is characterised in that: the raw material weight of the recipe ingredient It is as follows to measure component: Cordyceps militaris extract 1-1.5mg, oligofructose 1-2g, maltitol 1-1.5g, maltodextrin 0.5-2g.
3. a kind of quick anti-trioxypurine formula according to claim 1, it is characterised in that: the raw material weight of the recipe ingredient It is as follows to measure component: Cordyceps militaris extract 1.25g, oligofructose 1.5g, maltitol 1.25g, maltodextrin 1g.
4. a kind of quick anti-trioxypurine formula according to claim 1, which is characterized in that the preparation method is that:
S1: carrying out low temperature drying for the Cordyceps militaris of harvesting, rear to crush --- to impregnate --- enzymatic hydrolysis --- homogeneous --- secondary water proposes -- spray Mist is dry, obtains the Cordyceps militaris extract rich in cordycepin and selenium;
S2: mixing after oligofructose, maltitol, maltodextrin, Cordyceps militaris extract are sieved respectively, spare;
S3: the mixture in step 2 is sieved again, is then put into blender and is mixed;
S4: the mixture in step 2 is put into one-step-granulating method, carries out granulating process;
S5: mixture is cooling, and sterile workshop completes canned molding.
5. a kind of quick anti-trioxypurine formula according to claim 4, which is characterized in that mixed grit number 80 in the S2 Mesh.
6. a kind of quick anti-trioxypurine formula according to claim 4, which is characterized in that mixture crosses grit number in the S3 150-200 mesh.
7. a kind of quick anti-trioxypurine formula according to claim 4, which is characterized in that oligofructose, malt in the S4 It is irradiated before sugar alcohol, maltodextrin mixing by ultraviolet light, irradiation time 2 hours.
CN201910853787.9A 2019-09-10 2019-09-10 A kind of quick anti-trioxypurine formula Pending CN110448579A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910853787.9A CN110448579A (en) 2019-09-10 2019-09-10 A kind of quick anti-trioxypurine formula

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910853787.9A CN110448579A (en) 2019-09-10 2019-09-10 A kind of quick anti-trioxypurine formula

Publications (1)

Publication Number Publication Date
CN110448579A true CN110448579A (en) 2019-11-15

Family

ID=68491506

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910853787.9A Pending CN110448579A (en) 2019-09-10 2019-09-10 A kind of quick anti-trioxypurine formula

Country Status (1)

Country Link
CN (1) CN110448579A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112189849A (en) * 2020-10-28 2021-01-08 无锡市世纪生物工程有限公司 Uric acid reducing composition and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104473977A (en) * 2014-11-18 2015-04-01 广东省微生物研究所 Cordyceps militaris water extract as well as preparation method and application thereof
CN107788315A (en) * 2017-11-27 2018-03-13 威海养经堂医药科技有限公司 A kind of Cordyceps militaris LBP-X solid beverage

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104473977A (en) * 2014-11-18 2015-04-01 广东省微生物研究所 Cordyceps militaris water extract as well as preparation method and application thereof
CN107788315A (en) * 2017-11-27 2018-03-13 威海养经堂医药科技有限公司 A kind of Cordyceps militaris LBP-X solid beverage

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
王飞生等主编: "《食品营养卫生与健康》", 29 February 2016, 中国质检出版社、中国标准出版社 *
谢红旗等: "酶法提取蛹虫草中虫草素的研究", 《时珍国医国药》 *
邹琳等: "食品中降尿酸活性物质及其作用机理研究进展", 《食品工业科技》 *
钟明编著: "《以德养生:健康生活的金钥匙》", 31 May 2016, 贵州科技出版社 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112189849A (en) * 2020-10-28 2021-01-08 无锡市世纪生物工程有限公司 Uric acid reducing composition and preparation method thereof

Similar Documents

Publication Publication Date Title
CN109674958B (en) Traditional Chinese medicine composition with effect of reducing uric acid and preparation method and application thereof
CN108392519A (en) A kind of hypoglycemic composition and its preparation and application
CN1814167A (en) Health-care for diabetes
CN103445175B (en) Composition with effects of alleviating hangover and protecting liver
CN116832066B (en) Application of cuttlefish ink extract in preparing medicine for treating hyperkinetic syndrome and depression
CN105943958A (en) Inonotus obliquus composite solid particles for treating gout and preparing method thereof
CN110448579A (en) A kind of quick anti-trioxypurine formula
CN111956751A (en) Pharmaceutical composition for treating hyperuricemia and preparation method thereof
CN102614359B (en) Traditional Chinese medicine preparation for treating diabetes and preparation method thereof
CN103705796A (en) Medicinal composition for treating diarrhea, and preparation method thereof
CN102293928A (en) Chinese medicinal composition for treating hyperuricemia and urarthritis, and preparation method and application thereof
CN101946849B (en) Depressurization chewing gum and preparation method thereof
CN115137068A (en) Composition for reducing uric acid and application thereof
CN104173699B (en) A kind of chewable tablets of anti-treating dental ulcer and preparation method thereof
CN103908539A (en) Traditional Chinese medicine composition for treating hypertension as well as preparation method and application of traditional Chinese medicine composition
CN103393938B (en) Traditional Chinese medicine composition for reducing blood sugar
CN101244154B (en) Pharmaceutical combination for bearing and rearing better children, preventing birth defect and improving anamnesis
CN107281408A (en) A kind of hypoglycemic traditional Chinese medicine composition and preparation method thereof
CN107801830A (en) Teeth oral cavity cleansing tablet without gum with edible
CN115779046B (en) Traditional Chinese medicine composition, traditional Chinese medicine preparation and application for preventing and treating diabetes
CN100369616C (en) Glossy ganoderma essence liquid and its usage
CN100384437C (en) Botanical medicine for preventing and treating arteriosclerosis and regulating blood fat and its processing method
CN110755523B (en) Composition for improving hyperglycemia and preparation method thereof
CN101057901B (en) Traditional Chinese medicinal composition for curing hepatitis
CN101693086A (en) Traditional Chinese medicine compound preparation for preventing recurrent aphthae and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20191115